Stimulant-free fat loss and body composition improvement
InnoSlim® reduces intestinal glucose absorption (by downregulating SGLT1 glucose transporter) and activates AMPK-driven fat oxidation in adipocytes — producing fat loss without any stimulant, thyroid, or adrenal activation. Human studies confirm significant reductions in body weight, body fat percentage, and waist circumference with InnoSlim® supplementation.
Adiponectin elevation and insulin sensitivity
InnoSlim® significantly elevates adiponectin — the key insulin-sensitizing hormone secreted by healthy adipose tissue. Higher adiponectin improves muscle glucose uptake, reduces liver fat, and shifts whole-body metabolism toward fat oxidation rather than fat storage — a fundamental metabolic improvement relevant to obesity, metabolic syndrome, and type 2 diabetes prevention.
Blood glucose management
By reducing SGLT1-mediated glucose absorption in the intestine and improving peripheral insulin sensitivity through adiponectin elevation, InnoSlim® produces clinically relevant reductions in fasting blood glucose and postprandial glucose excursions — effects relevant for both weight management and metabolic health applications.
SGLT1 downregulation and AMPK activation
InnoSlim®'s specific ginsenoside profile (Rb1-dominant) downregulates SGLT1 (sodium-glucose cotransporter 1) in intestinal epithelium — reducing dietary glucose absorption into circulation. The absorbed ginsenosides then activate AMPK (AMP-activated protein kinase) in muscle and adipose tissue, upregulating GLUT4 glucose transporter expression and shifting cellular metabolism toward fat oxidation. Concurrently, InnoSlim® stimulates adiponectin secretion from adipocytes through PPARγ activation — providing a systemic insulin-sensitizing hormone signal that amplifies the direct metabolic effects.
Human clinical study of InnoSlim® (250 mg/day) effects on body weight, body fat, blood glucose, and adiponectin in overweight adults.
Overweight adults. Clinical assessment design.
InnoSlim® produced significant reductions in body weight, body fat percentage, and fasting blood glucose vs. control. Adiponectin levels significantly elevated. No stimulant-related side effects. Supports InnoSlim® as effective stimulant-free fat loss and metabolic health ingredient.